ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

May 29, 1987

Cell Behavior Changes Noted At Baltimore Symposium

January 8, 1982

In Brief: Lawsuit Could Delay Diet-Nutrition Cregs; Hugh Davis Replaces Mercado As CIB Chief

June 18, 1976

NCAB Settles PDQ Controversy; More CCOP Awards May Be Made, Center Guidelines Revisions Coming

October 7, 1983

IARC Director Denies NCI Staff Interference With Monograph

May 28, 1982

Foon To Direct Barrett Center; Hundahl Leads Commission

March 5, 1999